- Home
- AXR vs SRZN Comparison
AXR vs SRZN Comparison
Compare AXR & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXR
- SRZN
- Stock Information
- Founded
- AXR 1961
- SRZN 2015
- Country
- AXR United States
- SRZN United States
- Employees
- AXR N/A
- SRZN N/A
- Industry
- AXR Homebuilding
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- AXR Real Estate
- SRZN Health Care
- Exchange
- AXR Nasdaq
- SRZN Nasdaq
- Market Cap
- AXR 127.3M
- SRZN 117.8M
- IPO Year
- AXR N/A
- SRZN N/A
- Fundamental
- Price
- AXR $21.52
- SRZN $16.51
- Analyst Decision
- AXR
- SRZN Strong Buy
- Analyst Count
- AXR 0
- SRZN 2
- Target Price
- AXR N/A
- SRZN $38.50
- AVG Volume (30 Days)
- AXR 6.8K
- SRZN 110.2K
- Earning Date
- AXR 12-12-2025
- SRZN 11-07-2025
- Dividend Yield
- AXR N/A
- SRZN N/A
- EPS Growth
- AXR 40.98
- SRZN N/A
- EPS
- AXR 2.48
- SRZN N/A
- Revenue
- AXR $48,454,000.00
- SRZN $3,604,000.00
- Revenue This Year
- AXR $28.57
- SRZN N/A
- Revenue Next Year
- AXR N/A
- SRZN N/A
- P/E Ratio
- AXR $8.74
- SRZN N/A
- Revenue Growth
- AXR N/A
- SRZN N/A
- 52 Week Low
- AXR $17.60
- SRZN $5.90
- 52 Week High
- AXR $39.68
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- AXR 50.72
- SRZN 72.26
- Support Level
- AXR $19.69
- SRZN $12.79
- Resistance Level
- AXR $21.32
- SRZN $14.18
- Average True Range (ATR)
- AXR 1.02
- SRZN 0.92
- MACD
- AXR 0.20
- SRZN 0.37
- Stochastic Oscillator
- AXR 70.81
- SRZN 95.90
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).